pharmaceutical investing Verona Pharma plc Operational Update and Financial Results for the First Quarter Ended March 31, 2018
medical device investing AIT Therapeutics Receives Patent Allowance for Delivery of Inhaled Nitric Oxide at Concentrations of at Least 160ppm for Treatment of Bronchiolitis in Infants
pharmaceutical investing Verona Pharma Reports Positive Top-Line Data from Phase 2b Clinical Trial of RPL554
Stallion Uranium to Resume Trading on the TSX-V and Enters into Agreement to Sell Shares of 1503571 B.C. LTD.
BTV Highlights: North American Iron, West Red Lake Gold Mines, Northisle Copper and Gold, Westport Fuels, US Gold, Orvana Minerals, Avino Silver & Gold, Pasofino Gold, & Mayfair Gold